Register entry
- Registered sites
- 0
- Active NDC listings
- 1
- Live patents
- 6
- Countries
- 0
Exclusivity
Patents and exclusivities
6| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 9550036 | TRUDHESAdihydroergotamine mesylate | product | Sept 2032 |
| 10507295 | TRUDHESAdihydroergotamine mesylate | product | Dec 2032 |
| 10940278 | TRUDHESAdihydroergotamine mesylate | product | Jan 2033 |
| 9919117 | TRUDHESAdihydroergotamine mesylate | product | Mar 2033 |
| 11266799 | TRUDHESAdihydroergotamine mesylate | product | Nov 2036 |
| 11185497 | TRUDHESAdihydroergotamine mesylate | use | Jan 2039 |
Catalogue
Marketed products
1| Brand | Generic name | Form / route | NDC |
|---|---|---|---|
| Trudhesa | Dihydroergotamine mesylate | spray, metered, nasal | 77530-725NDA |
Compare
Other companies listing dihydroergotamine mesylate
- Teva Czech Industries s.r.o.1 site · 41 NDC
- Trifluent Pharma LLC1 site · 38 NDC
- TAPI Czech Industries s.r.o.1 site · 32 NDC
- Advagen Pharma Limited0 sites · 213 NDC
Enquiry
Common questions
- Is Impel Pharmaceuticals LLC FDA approved?
- Impel Pharmaceuticals LLC holds no registered establishment of its own; 1 drug product is listed under its name in the National Drug Code Directory, made at sites registered to other firms.
- What drugs does Impel Pharmaceuticals LLC make?
- 1 product is listed under Impel Pharmaceuticals LLC in the openFDA NDC Directory, most often as spray, metered. The full breakdown by dosage form and route is above. A listing count is not a sales figure.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.